Literature DB >> 16835328

A role for XRCC4 in age at diagnosis and breast cancer risk.

Kristina Allen-Brady1, Lisa A Cannon-Albright, Susan L Neuhausen, Nicola J Camp.   

Abstract

Genetic variants in DNA repair genes influence the ability to repair damaged DNA. Unrepaired or improperly repaired DNA may lead to genetic instability and carcinogenesis. We evaluated the role of four tagging single nucleotide polymorphisms (tSNP) in the DNA repair gene, XRCC4, and its association with breast cancer risk and age at diagnosis of breast cancer in 464 cases and 576 controls selected to be BRCA1/2 mutation negative from high-risk Utah pedigrees. We observed a significant association for two 4-locus tSNP haplotypes and age at diagnosis. Carriage of one haplotype was associated with later diagnosis (haplotype frequency, 0.039; mean age at diagnosis, 67.17 years; P = 0.001), and carriage of the other was associated with earlier diagnosis (haplotype frequency, 0.214; mean age at diagnosis, 54.04 years; P = 0.0085). For breast cancer risk, two 2-locus tSNP haplotypes explained the observed association as well as extended four-locus haplotypes. The two 2-locus haplotypes were nominally associated with breast cancer risk, one for reduced risk (odds ratio, 0.57; 95% confidence interval, 0.36-0.90; P = 0.014) and one for increased risk (odds ratio, 1.30; 95% confidence interval, 1.02-1.67; P = 0.033). Moreover, one of the tSNPs is in strong linkage disequilibrium (D' = 1.00) with an XRCC4 SNP found to be significantly associated with breast cancer risk in Taiwan, hence, confirming their findings. Our results suggest that XRCC4 may play a role in the age at diagnosis and risk of breast cancer in non-BRCA1/2, heritable breast cancer cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16835328     DOI: 10.1158/1055-9965.EPI-05-0959

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  8 in total

1.  Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer.

Authors:  Suliman Y Alomar; Afrah Alkhuriji; Paul Trayhyrn; Abdulkarim Alhetheel; Abdullah Al-Jurayyan; Lamjed Mansour
Journal:  Immunogenetics       Date:  2016-09-15       Impact factor: 2.846

2.  DNA double-strand break repair genotype and phenotype and breast cancer risk within sisters from the New York site of the Breast Cancer Family Registry (BCFR).

Authors:  Hui-Chen Wu; Lissette Delgado-Cruzata; Nicola Machella; Qiao Wang; Regina M Santella; Mary Beth Terry
Journal:  Cancer Causes Control       Date:  2013-09-24       Impact factor: 2.506

3.  A role for XRCC2 gene polymorphisms in breast cancer risk and survival.

Authors:  Wei-Yu Lin; Nicola J Camp; Lisa A Cannon-Albright; Kristina Allen-Brady; Sabapathy Balasubramanian; Malcolm W R Reed; John L Hopper; Carmel Apicella; Graham G Giles; Melissa C Southey; Roger L Milne; Jose I Arias-Pérez; Primitiva Menéndez-Rodríguez; Javier Benítez; Magdalena Grundmann; Natalia Dubrowinskaja; Tjoung-Won Park-Simon; Thilo Dörk; Montserrat Garcia-Closas; Jonine Figueroa; Mark Sherman; Jolanta Lissowska; Douglas F Easton; Alison M Dunning; Preetha Rajaraman; Alice J Sigurdson; Michele M Doody; Martha S Linet; Paul D Pharoah; Marjanka K Schmidt; Angela Cox
Journal:  J Med Genet       Date:  2011-05-31       Impact factor: 6.318

4.  PedGenie: meta genetic association testing in mixed family and case-control designs.

Authors:  Karen Curtin; Jathine Wong; Kristina Allen-Brady; Nicola J Camp
Journal:  BMC Bioinformatics       Date:  2007-11-15       Impact factor: 3.169

5.  A recessive variant of XRCC4 predisposes to non- BRCA1/2 breast cancer in chinese women and impairs the DNA damage response via dysregulated nuclear localization.

Authors:  Min He; Xin Hu; Li Chen; A-Yong Cao; Ke-Da Yu; Ting-Yan Shi; Xia-Ying Kuang; Wen-Biao Shi; Hong Ling; Shan Li; Feng Qiao; Ling Yao; Qingyi Wei; Gen-Hong Di; Zhi-Ming Shao
Journal:  Oncotarget       Date:  2014-12-15

6.  The diagnostic value of DNA repair gene in breast cancer metastasis.

Authors:  Yongxin Yang; Xiabin Li; Liyue Hao; Deyong Jiang; Bin Wu; Tao He; Yan Tang
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

7.  Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes.

Authors:  Veronika Vymetalkova; Pavel Soucek; Tereza Kunicka; Katerina Jiraskova; Veronika Brynychova; Barbara Pardini; Vendula Novosadova; Zdena Polivkova; Katerina Kubackova; Renata Kozevnikovova; Miloslav Ambrus; Ludmila Vodickova; Alessio Naccarati; Pavel Vodicka
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

8.  Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer.

Authors:  Wei-Yu Lin; Ian W Brock; Dan Connley; Helen Cramp; Rachel Tucker; Jon Slate; Malcolm W R Reed; Sabapathy P Balasubramanian; Lisa A Cannon-Albright; Nicola J Camp; Angela Cox
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.